loading
Genenta Science Spa Adr stock is traded at $4.81, with a volume of 1,137. It is down -4.18% in the last 24 hours and down -12.55% over the past month. Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
See More
Previous Close:
$5.02
Open:
$5.05
24h Volume:
1,137
Relative Volume:
0.09
Market Cap:
$89.62M
Revenue:
-
Net Income/Loss:
$-12.63M
P/E Ratio:
-10.00
EPS:
-0.4808
Net Cash Flow:
$-12.18M
1W Performance:
-0.97%
1M Performance:
-12.55%
6M Performance:
+45.76%
1Y Performance:
-10.93%
1-Day Range:
Value
$4.90
$5.05
1-Week Range:
Value
$4.61
$5.44
52-Week Range:
Value
$2.20
$7.28

Genenta Science Spa Adr Stock (GNTA) Company Profile

Name
Name
Genenta Science Spa Adr
Name
Phone
-
Name
Address
-
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
GNTA's Discussions on Twitter

Compare GNTA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
GNTA 4.90 89.62M 0 -12.63M -12.18M -0.4808
VRTX 467.19 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.91 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 566.22 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.54 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.55 24.08B 3.30B -501.07M 1.03B 11.54

Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-29-23 Resumed ROTH MKM Buy
Jul-25-22 Initiated H.C. Wainwright Buy
Jan-13-22 Initiated Maxim Group Buy

Genenta Science Spa Adr Stock (GNTA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):